Magenta therapeutics reports recent business highlights and third quarter financial results

Cambridge, mass.--(business wire)--magenta therapeutics (nasdaq: mgta), a clinical-stage biotechnology company developing novel medicines to bring the curative power of immune reset to more patients, today reported recent business highlights and financial results for the third quarter ended september 30, 2020. “magenta showed steady progress throughout the third quarter, bringing aboard new scientific leadership in lisa olson to broaden our technical expertise across research and discovery. we
DNTH Ratings Summary
DNTH Quant Ranking